Skip to main content

Advertisement

Table 1 Clinicopathological features of KCNMA1 promoter methylation in 112 patients with GC

From: KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome

Factors Methylated (N = 77) Non-methylated (N = 35) P value
Age (mean ± SD) 64.44 ± 1.00 61.81 ± 1.86 0.182
Gender
 Male 50 22 0.879
 Female 27 13  
Tumor sizes
  ≤ 5 cm 35 26 0.005
  > 5 cm 42 9  
Depth of invasion
 T1+ T2 17 2 0.032
 T3+ T4 60 33  
Lymphnode metastasis
 N0 22 7 0.808
 N1 23 12  
 N2 17 9  
 N3 15 7  
Metastasis
 M0 67 29 0.560
 M1 10 6  
TNM stages
 I 9 2 0.687
 II 19 11  
 III 38 16  
 IV 11 6  
  1. The entries in bold showed the P value is less than 0.05